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Abstract
As circulating monocytes enter the site of disease, the local microenvironment instructs
their differentiation into tissue macrophages (MΦ). To identify mechanisms that regulate
MΦ differentiation, we studied human leprosy as a model, since M1-type antimicrobial MΦ
predominate in lesions in the self-limited form, whereas M2-type phagocytic MΦ are charac-
teristic of the lesions in the progressive form. Using a heterotypic co-culture model, we
found that unstimulated endothelial cells (EC) trigger monocytes to become M2 MΦ. How-
ever, biochemical screens identified that IFN-γ and two families of small molecules acti-
vated EC to induce monocytes to differentiate into M1 MΦ. The gene expression profiles
induced in these activated EC, when overlapped with the transcriptomes of human leprosy
lesions, identified Jagged1 (JAG1) as a potential regulator of MΦ differentiation. JAG1 pro-
tein was preferentially expressed in the lesions from the self-limited form of leprosy, and
localized to the vascular endothelium. The ability of activated EC to induce M1 MΦ was
JAG1-dependent and the addition of JAG1 to quiescent EC facilitated monocyte differentia-
tion into M1 MΦ with antimicrobial activity againstM. leprae. Our findings indicate a poten-
tial role for the IFN-γ-JAG1 axis in instructing MΦ differentiation as part of the host defense
response at the site of disease in human leprosy.
Author Summary
Mycobacterial diseases, such as leprosy, continue to be serious causes of mortality and
morbidity worldwide. They pose a unique treatment challenge due to their ability to mod-
ify the immune response in infected individuals. For example, in leprosy there are two dis-
tinct manifestations of the disease, each characterized by the immune response of the
individual. One results in a more disseminated and severe form of the disease, lepromatous
leprosy, and the other is a more limited form with marked antimicrobial activity,
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tuberculoid leprosy. These differences in the immune response can be characterized by the
phenotype and activation state of the macrophage. We illustrate how the local endothelial
microenvironment can “educate” macrophages, identifying Jagged1 and select small mole-
cules that can regulate this pathway. Therefore, these studies identify a potential strategy
to intervene in infection and inflammation, by targeting macrophage instruction at the site
of disease. Through the integration of in vitromodeling and gene expression profiles at the
site of disease, we found that Jagged 1 harnesses the endothelial microenvironment to
instruct antimicrobial macrophage responses in leprosy.
Introduction
When circulating monocytes enter the site of disease, local cues from the tissue microenviron-
ment direct their differentiation into specialized MF equipped for diverse tasks [1–3]. While
classically activated M1 MF with antimicrobial activity promote host defense against intracel-
lular pathogens, alternatively activated (M2) MF perform homeostatic functions including
phagocytosis critical to tissue remodeling [1–6]. In leprosy, the divergence of MF functional
programs correlate with the clinical disease spectrum [7–9]. In the self-limited, tuberculoid (T-
lep) form of leprosy, disease lesions contain well-organized granulomas with M1MF, express-
ing the MFmarker CD209, but negative for the haptoglobin receptor CD163, yet armed with
antimicrobial effector function [7]. By contrast, in the progressive, lepromatous (L-lep) form of
leprosy, patient lesions are characterized by disorganized granulomas containing MF which
co-express CD209 and CD163 but lack antimicrobial activity. Instead, these MF are pro-
grammed with phagocytic function, which results in the accumulation of host-derived lipids
and favors mycobacterial growth [10, 11], and are therefore referred to as M2 MF. These data
raise the question regarding the mechanisms by which clues from the microenvironment influ-
ence MF programming at the site of infection.
As a gatekeeper to circulating monocytes that enter disease lesions, the microvasculature is
poised to deliver key differentiation cues. The very cells which allow monocytes to exit the
blood and enter the site of disease, i.e. EC, were shown to trigger monocyte differentiation into
MF [12], specifically of the M2 type [13]. Therefore, unstimulated EC have the ability to
instruct M2 MF differentiation, yet the conditions that might alter EC to instruct M1 MF dif-
ferentiation are not known. Here, we explore how the EC-monocyte interface can influence
M1 MF differentiation, including upregulation of antimicrobial activity, in the context of lep-
rosy as a human disease model.
Results
Given the critical role the microvasculature plays in the transmigration of circulating leuko-
cytes, it is poised to deliver instructive cues to monocytes entering the site of disease [12, 14,
15]. To investigate how the microvasculature, specifically EC, influence MF differentiation, we
chose leprosy as a model, focusing on M1 and M2 MF that expressed CD209, and the relative
expression of CD163, either low and high, reflecting the major MF phenotypes at the site of
disease and endowed with distinct functional programs. We hypothesized that a resting micro-
environment leads EC to instruct monocyte differentiation into M2 MF with phagocytic func-
tion; whereas, perturbations in the local microenvironment may direct monocytes to
differentiate into M1 MF with antimicrobial activity (Fig 1A).
When human monocytes were cultured in the presence of several types of EC, but not vas-
cular smooth muscle cells, we observed differentiation of monocytes into MF expressing
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Fig 1. The microenvironment influences CD209+macrophage differentiation. (A) Hypothesis: the activation
state of the microenvironment instructs monocytes to differentiate into either homeostatic or antimicrobial
CD209+MΦ. (B) A panel of regulatory cytokines were tested for their capacity to mediate EC-driven
antimicrobial CD209+MΦ differentiation; results represent mean +/- SEM from three independent experiments
performed in triplicate wells, ** p value < 0.01. (C) Representative log scale dot plots of media and IFN-γ treated
ECs. (D) Compiled data comparing MΦ triggered by resting vs. IFN-γ treated EC, (n = 22 independent
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CD209 (S1 Fig). As a first step to explore how the endothelial microenvironment may influence
M1 vs. M2 MF differentiation, EC were treated with various regulatory cytokines before add-
ing human peripheral blood mononuclear cells. After co-culture for 48h, monocyte differentia-
tion was assessed by flow cytometry. For most of the cytokines used in the pre-treatment, EC
triggered differentiation into a comparable percentage of M2 MF co-expressing CD209 and
CD163 (Fig 1B). However, only IFN-γ-treated EC facilitated monocyte differentiation into the
CD209+CD163neg M1 MF phenotype associated with host defense [7, 16]. These M1 MF also
expressed higher levels of CD40 [17, 18] (Fig 1C and 1D), but not the dendritic cell marker
CD1a (S2 Fig). To assess whether this effect was specific to the Type II IFN, IFN-γ, we also
tested the Type I IFN, IFN-α, which failed to mediate similar EC-triggered MF differentiation
(Fig 1E). Monocyte differentiation into CD209+ MF was dependent on direct contact with EC
and did not occur when monocytes were treated with IFN-γ in the absence of EC (S3A and
S3C Fig). While the addition of IFN-γ induces very low levels of CD209 on human monocytes,
direct contact with ECs elicits the highest expression of CD209 on differentiating MF(S3A and
S3C Fig). In addition, similar results were obtained with purified CD14+CD16neg monocytes,
indicating the process was independent of lymphocytes (S3B Fig).
Next, we compared the MF derived from activated vs. resting EC for antimicrobial vs.
phagocytic characteristics, given that our previous studies showed these programs to be diver-
gent [7]. The M1 MF (CD209+CD163neg) induced by IFN-γ-treated EC, when compared to
the M2 MF induced by resting EC (CD209+CD163+), were found to: i) take up less oxidized
low density lipoprotein (oxLDL) (p<0.01) (Fig 1F), ii) produce greater amounts of pro-inflam-
matory cytokines in response to stimulation with a mycobacterial TLR2/1 ligand (p<0.05)
(Fig 1G), and iii) express greater levels of the vitamin D antimycobacterial pathway genes
Cyp27b1, VDR and cathelicidin [7] (Fig 1H). Therefore, IFN-γ, which is known to play a criti-
cal role in host defense againstM. leprae and other mycobacterial pathogens [4, 8, 19, 20],
licensed the EC to instruct monocyte differentiation into M1 MF programmed with upregula-
tion of the vitamin D antimicrobial pathway.
Diverse compounds can facilitate endothelial cell-driven antimicrobial
macrophages
IFN-γ is a potent inflammatory mediator that regulates an extensive gene program in EC [19–
21]. We envisioned that small molecules that would facilitate EC-driven M1MF differentia-
tion may do so through convergence upon shared regulatory mechanisms (Fig 2). From a small
molecule library generated by diversity-oriented synthesis (n = 642) [22], 24 compounds
(3.7%) were identified which when used to treat EC, promoted M1 MF differentiation as mea-
sured by cell surface phenotype (Fig 3A). Two structurally distinct families, naphthyridines
and tetrahydro-pyrrolo-triazolo-pyridazindiones (tptp) accounted for 13 (54%) of the “hits”,
and subsequent experiments with compounds from each of these families confirmed that upon
treatment of EC, they triggered differentiation of M1 MF (Fig 3B). As with IFN-γ, this effect
was EC-dependent, since the compounds failed to directly trigger monocytes to become MF
that express CD209 (S4 Fig). Among 81 naphthyridine analogs [22], 34 (42%) prompted EC to
instruct monocyte differentiation into M1MF (S5 Fig), indicating some specificity among
experiments, * p value < 0.05, ** p value < 0.01, *** p value < 0.001). (E) Representative log scale dot plots of
media, IFN-γ and IFN-α treated cultures. Functional characterization of MΦ, as determined by (F) phagocytosis
of Dil-oxLDL, (G) CD14+ MΦ cytokine production in response to TLR2/1L stimulation, and (H) up regulation of
the vitamin D pathway in CD14+ MΦ (Cath, cathelicidin antimicrobial peptide (CAMP)). Data represent the mean
+/- SEM from at least three independent donors performed in triplicate wells (* p value < 0.05, ** p value < 0.01,
*** p value < 0.001).
doi:10.1371/journal.ppat.1005808.g001
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naphthyridines. As with IFN-γ treated EC cultures, M1 MF derived from the compound-acti-
vated EC cultures were significantly less phagocytic than the M2 MF derived from the resting
EC cultures (p< 0.0001) (Fig 3C and 3D). We chose the most effective compound (naphthyri-
dine 105A10) for further analysis and found that 105A10-treated EC triggered MF that were
also more responsive to TLR2/1 activation in terms of induction of pro-inflammatory cyto-
kines (Fig 3E).
Identification of candidate regulatory genes leading to the induction of
antimicrobial M1 MΦ in leprosy
Having identified structurally diverse compounds that mimicked IFN-γ, we sought to use these
compounds to explore the mechanisms by which EC trigger this differentiation. Since IFN-γ
signaling is primarily through STAT-1, we sought to determine if active compounds from both
families increased the phosphorylation of STAT-1 in treated EC. Active compounds from both
tptp and naphthyridine families of compounds failed to induce phosphorylated STAT-1 (Fig
4A). To determine whether the various stimuli induce a common gene signature in EC, we
measured the gene expression profiles in EC treated with either IFN-γ, IFN-α or one of four
active small molecules (two naphthyridines: 105A9, 105A10 and two tptp family members:
104B11, 104C2). IFN-γ induced a broad profile (n = 3675 probes>1.25-fold induction), by
comparison, the four compounds induced a more restricted profile, (range n = 1248–1935
probes>1.25-fold induction). A high proportion of the genes induced by the four compounds
(24–29%) overlapped with the IFN-γ signature (hypergeometric p values for enrichment:
5.35 x 10−32 to 2.80 x 10−103, Fig 4B).
Fig 2. Overview of experimental design. After identification of unique activators of endothelium-directed MΦ
differentiation (top), transcriptomes from activated endothelium were compared to the leprosy transcriptome to
identify potential regulators of anti-microbial MΦ differentiation at the site of disease.
doi:10.1371/journal.ppat.1005808.g002
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Fig 3. Small molecules can facilitate endothelial-driven antimicrobial MΦ. (A) Endothelial cells were treated with a small molecule library
(n = 642, 10 μM) for 5 hours. EC were washed, primary mononuclear cells were added, and CD209+MΦ differentiation was assessed by flow
cytometry. Polarizing compounds were selected by their capacity to drive the antimicrobial CD209+MΦ phenotype (CD209+CD163low gate). Two
structural families (tptp and naphthyridine) accounted for 54% of the hits, as defined by > 3 s.d. from the mean (dashed line). (B) Phenotypic
validation of active tptp and naphthyridines; data represent mean and SEM of three donors (* p value < 0.05, ** p value < 0.01). (C,D)
Phagocytosis of Dil-oxLDL by antimicrobial CD209+MΦ differentiated in culture with compound-treated endothelium, and correlation between
Jagged1 Instructs Macrophage Differentiation in Leprosy
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To identify the genes triggered in activated EC with relevance to leprosy, we overlapped
three profiles: i) induced by IFN-γ in EC, ii) induced by at least one of the four small molecules
in EC; and, iii) preferentially expressed at the site of disease in the self-limited T-lep vs. the pro-
gressive L-lep form of leprosy (Figs 2 and 5A). This analysis identified 166 candidate regulatory
genes, of which 50 were induced by at least two of the four compounds (S1 Table).
We next tested the role of the 50 common genes in facilitating EC-directed M1 MF differ-
entiation. EC were transfected with siRNA against each of these candidate genes, and then
treated with IFN-γ to induce the M1 polarizing microenvironment, followed by co-culture
with primary human PBMC. In this context, monocyte differentiation into CD163+ MF
would reflect that the M1 MF-polarizing effect of IFN-γ treated EC was being inhibited by the
siRNA. Across five separate experiments, eight genes significantly inhibited the effect that IFN-
γ exerts on the EC-driven M1 MF phenotype (Fig 5B, S6 Fig). In parallel, the gene expression
profiles of the 50 common genes were examined in leprosy lesions, with the premise that
inverse correlation with CD163 expression may indicate a role in regulating M1 MF differenti-
ation at the site of disease. Among the top eight candidate genes, JAG1 demonstrated the stron-
gest inverse correlation with CD163 expression across the spectrum of leprosy lesions (r =
-0.834, R2 = 0.6956, P<0.0001, T-lep lesions n = 10, L-lep lesions n = 6), with greater expres-
sion in T-lep vs. L-lep lesions (fold change 2.2, p<0.0002) (Fig 5B and 5C).
CD163 expression and DiI-oxLDL uptake. (E) TLR2/1L responsiveness by CD14+MΦ derived from resting vs. naphthyridine (105A10) treated EC.
Data represent the mean +/- SEM from three independent experiments performed in triplicate wells (* p value < 0.05, ** p value < 0.01).
doi:10.1371/journal.ppat.1005808.g003
Fig 4. Comparative analysis of IFN-γ, IFN-α, and active small molecules. (A) Effect of IFN-γ vs. active compounds on
STAT1 phosphorylation (t = 15 min) in human EC; representative of three experiments. (B) Gene expression profiling of EC
treated with IFN-γ, IFN-α, 2 tptp family members (104B11, 104C2) and 2 naphthyridines (105 A9, 105A10). Number of probes
(>1.25), % overlap with IFN-γ, and hypergeometric p values for over-enrichment (relative to IFN-γ) are indicated.
doi:10.1371/journal.ppat.1005808.g004
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Fig 5. Comparative transcriptome analysis identifies JAG1 as a putative regulator anti-microbial MΦ differentiation in
leprosy. (A) Genes induced in EC (FC > 1.25) by IFN-γ, naphthyridines (105 A9 and A10) and tptps (104 B11 and C2) were
predicted to contain genes that also influence CD209+MΦ polarization in leprosy. Probes selectively induced (FC> 1.25) by IFN-γ
and active compound treatment of the endothelium were integrated with leprosy lesions (T-lep > L-lep, FC 1.25). (B) siRNA
knockdown of the top 50 candidate regulatory genes: data represent effect on IFN-γ driven effects on CD163 expression during
MΦ differentiation. (* p value < 0.05) (C) The effect of siRNA-mediated candidate gene regulation was correlated with CD163
Jagged1 Instructs Macrophage Differentiation in Leprosy
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After confirming that JAG1 is induced on EC following stimulation with IFN-γ (S7 Fig), we
then assessed JAG1 expression at the site of disease. JAG1 expression in leprosy lesions was val-
idated by immunohistochemistry, which demonstrated that JAG1 was expressed within the
dermis and the granulomas in T-lep, but not L-lep lesions (Fig 5E, S8 Fig). We also noted peri-
vascular labeling of JAG1 in proximity to CD209+ MF (Fig 5F), as well JAG1 expression in the
microanatomic locations in which M1 MF (CD209+CD163neg) were found (Fig 5F). In addi-
tion, there appeared to be JAG1 staining in the epidermis of both the T-lep and L-lep lesions
which is consistent with the known role of JAG1 in keratinocyte differentiation and maturation
[23, 24]. Blinded analysis of JAG1 immunohistochemical staining determined a significant
(p = 0.0063) increased positive staining in T-lep sections, scores ranged from 0 (absent) to 4
(highly positive). Together, these data indicated that JAG1 expression correlated with M1 MF
accumulation at the site of disease in leprosy.
JAG1 triggers antimicrobial macrophages in an endothelial cell-
dependent manner
We next investigated whether JAG1 could instruct the differentiation of monocytes into M1
MF with antimicrobial function. We found that soluble JAG1 (sJAG1) facilitated EC-driven
M1 MF differentiation (Fig 6A and 6B). Furthermore, overexpression of JAG1 in EC, as well
as addition of a JAG1 agonist peptide to the co-cultures, induced the differentiation of mono-
cytes into the M1 MF phenotype (S9 Fig). In contrast, addition of sJAG1 to monocytes alone
did not induce MF differentiation (S10 Fig). Given that JAG1 is known to activate Notch 1 sig-
naling, we determined whether Notch-downstream genes were upregulated by the addition of
JAG1 to the EC/monocyte co-cultures. In comparison to untreated EC, the addition of JAG1
led to the mRNA upregulation of three prototypic Notch-downstream genes in MF, HES1,
SOCS3 and RBPJ (S11 Fig).
Differentiation of monocytes in the presence of sJAG1 and EC yielded M1 MF with
decreased phagocytosis (Fig 6C) and heightened induction of vitamin D-dependent antimicro-
bial pathway genes (Fig 6D). To determine whether EC treated by either IFN-γ or JAG1
induced differentiation of monocytes into MF with antimicrobial activity, MF differentiated
in the presence of treated EC were infected with liveM. leprae, and the antimicrobial response
measured according to the ratio ofM. leprae RNA to DNA [25, 26] (Fig 6E). As compared to
MF differentiated in the presence of resting EC (i.e. treated with media), the MF induced by
culture with EC treated with either IFN-γ or sJAG1 showed significant antimicrobial activity.
Therefore, when monocytes encounter JAG1 in the context of EC, a differentiation program is
triggered, resulting in M1MF, defined by a CD209+CD163neg phenotype and antimicrobial
function. The presence of IFN-γ, JAG1-expressing EC and CD209+CD163neg MF in the self-
limited form of leprosy suggests that the IFN-γ-JAG1-antimicrobial MF differentiation path-
way contributes to host defense at the site of disease in leprosy.
Discussion
Our understanding of MF immunobiology has been significantly advanced through under-
standing of the pathways by which microbial ligands and/or cytokines program monocytes to
differentiate into M1 and M2MF [27, 28]. However, it is not clear how local tissue signals can
gene expression in the leprosy data set (T-Lep = 10, L-lep = 6), with JAG1 (D) emerging as a lead candidate regulatory gene. (E)
Immunohistochemistry (representative of T-lep, n = 6 and L-lep, n = 4) and (F) confocal microscopy (one lesion, representative of
n = 3) localizes JAG1 (IHC-red stain) expression in T-lep lesions with preferential expression in areas with CD209+CD163neg MΦ
and the vascular marker vWF.
doi:10.1371/journal.ppat.1005808.g005
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differentially program the MF response. Signals from endothelium are involved; this default
pathway triggers M2 MF differentiation [13]. However, the mechanisms by which monocytes,
upon entering the site of disease via the endothelium, are instructed to differentiate into M1
MF remain elusive [1–3]. Here, we hypothesized that if EC were to encounter the proper sig-
nals, the EC microenvironment would instruct monocytes to differentiate into M1 MF,
equipped for host defense against intracellular pathogens at the site of disease. By studying lep-
rosy as a model, we provide evidence that upregulation of JAG1 on endothelium instructs
monocytes to differentiate into M1MF with antimicrobial activity.
Our data indicate that the induction of JAG1 is involved in EC instruction of M1 MF differ-
entiation. In addition, the concomitant induction of Notch 1-downstream genes including
HES1, SOCS3 and RBP-J mRNAs was detected in the differentiated M1 MF. These findings
are consistent with the known ability of JAG1 to signal via Notch 1 receptors [29], and with
reports that Notch 1 signaling, via SOCS3 and RBP-J [30–32] through reprogramming of mito-
chondrial metabolism [33], contributes to M1 MF differentiation. Nevertheless, since JAG1 is
known to signal via several distinct receptors [34, 35], further work is necessary to identify the
physiologically relevant interactions responsible for EC-driven M1 MF differentiation. Not
only does IFN-γ induce JAG1 on EC which can influence monocyte differentiation, IFN-γ also
augments TLR-induced regulation of JAG1 expression in differentiated MF [36]. Further
Fig 6. JAG1 facilitates antimicrobial CD209+MΦ differentiation. (A, B) JAG1 (250ng/ml) added to EC/primary
mononuclear cell co-cultures (CC) promotes the antimicrobial CD209+MΦ phenotype (representative log scale dot plots,
and mean +/- SEM of n = 6 experiments, * p value < 0.05). Functional characterization of MΦ as determined by (C)
phagocytosis of Dil-oxLDL, (D) induction of the vitamin D pathway in CD14+MΦ and (E) antimicrobial ability. For
antimicrobial ability determination, co-culture derived CD14+MΦwere infected withM. leprae (MOI 10:1) overnight. After
infection, cells were treated with IFN-γ and supplemented with 25-D3 for a period of five days. Determination ofM. leprae
viability was calculated using the ratio of bacterial 16S RNA and DNA (RLEP) as quantified by qPCR. Data represent the
mean +/- SEM from at least three independent donors (* p value < 0.05, * * p value < 0.01).
doi:10.1371/journal.ppat.1005808.g006
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studies will be required to elucidate how JAG1 can contribute to MF differentiation, plasticity,
function and proliferation at the site of disease [37].
In addition to the role of JAG1 in regulating innate immune responses via MF differentia-
tion, evidence suggests a role for JAG1 in regulating adaptive T cell responses. Patients with
Alagille syndrome, in which JAG1 mutations result in a multisystem disorder [34, 38], can
exhibit altered Th1 responses [35], implicating JAG1 induced signaling in T cell differentiation.
In vitro studies have also shown that JAG1 expression on keratinocytes promotes dendritic cell
maturation, which could also influence T cell responses [39]. Therefore, the expression of
JAG1 by resident cells in tissue can influence both innate and adaptive immune responses.
Under resting conditions, EC instruct monocytes to differentiate in M2MF [13]. M2 MF
are highly phagocytic, and are involved in clearing various biomolecules relevant for tissue
repair, removal of excess metabolic products as well as clearance of debris. However, in the
context ofM. leprae infection, M2 MF can phagocytize the bacteria, but are unable to mount
an antimicrobial response. Furthermore, these M2 MF take up host-derived lipids, providing
necessary nutrients for mycobacterial growth [40]. Therefore, the induction of M1 MF is
required for host defense against this intracellular pathogen, as these MF are weakly phago-
cytic but exhibit a strong antimicrobial response. One direct signal at the site of infection is
production of IL-15, which directly triggers M1 MF differentiation. In addition, our data dem-
onstrates that IFN-γ induces JAG1 expression on EC, which also facilitates differentiation of
monocytes into M1 MF. In the self-limited form of leprosy, JAG1 expression is restricted to
microanatomical regions of the granuloma enriched for M1 MF. Therefore, our findings sup-
port the concept that the IFN-γ-JAG1 axis is involved in the EC instruction of the antimicro-
bial MF response againstM. leprae at the site of infection.
The ability to model how the microenvironment influences the immune response at the site
of disease has become feasible because of advances in analyzing increasingly complex systems.
We used a cell co-culture system in which we integrated small molecule screening with gene
expression profiles to look for recurrent motifs in gene activation patterns associated with EC-
triggering M1MF. Since none of the molecular signals we identified recapitulate the antimi-
crobial MF phenotype on their own, our findings indicate that the emergent properties inher-
ent to more complex heterotypic systems allowed for their discovery [41]. As such, this
approach provides a strategy to identify potential drugs or biologic agents that would otherwise
not be identified in experiments exploring direct effects on monocyte differentiation into anti-
microbial MF. The identification of JAG1 and other small molecules that can harness the local
microenvironment to augment innate immune responses at the site of disease may hold prom-
ise for combating intracellular pathogens.
Materials and Methods
Reagents
IFN-γ and IL-4 (Peprotech) were used at 10ng/ml. IFN-α (PBL Interferon Source) was used at
10ng/ml. IL-15 (25ng/ml), IL-10 (10ng/ml), IL-5 (10ng/ml), fc-JAG1 (250ng/ml) and fc-con-
trol (250 ng/ml) were purchased from R&D Systems. JAG1 protein active peptide fragment
(1μM) was purchased from Phoenix Pharmaceuticals. Small molecule compound libraries and
analogs were synthesized in the Ohyun Kwon laboratory. Compounds were dissolved in
DMSO and used at a final concentration of 10 μM.
Co-culture experiments
Co-culture experiments were carried out as previously described [22]. In short, Primary
human endothelial cells (EC) were plated to confluence in a 96 well plate. After adherence,
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endothelial cells were activated by indicated treatments for a period of 5 hours and subse-
quently washed 2–3 times to ensure removal of activation treatment. We then added human
peripheral blood mononuclear cells (PBMC) at a ratio of 3 PBMC to 1 EC. Cultures were incu-
bated at 37°C and 7% CO2 for a period of 48hrs. Human Umbilical Vein Endothelial Cells
(HUVEC) were purchased from Lonza and used from passages 4–8. Peripheral blood mononu-
clear cells were isolated from healthy donors (UCLA Institutional Review Board # 92-10-591-
31) using Hypaque Ficoll gradients (GE Healthcare).
Clinical samples
Samples were retrieved by skin biopsy from patients with leprosy. The designation of tubercu-
loid leprosy (T-lep) and lepromatous leprosy (L-lep) was determined according to the criteria
of Ridley and Jopling. Patient skin biopsies were performed at the time of diagnosis and subse-
quently embedded in OCT medium (Ames, Elkhart, IN), snap frozen in liquid nitrogen and
stored at -80°C (24).
Determination of STAT-1 phosphorylation
HUVEC were stimulated with IFN-γ and compounds (104 B11, 104 C2, 105 A9 and 105 A10)
for 15 minutes and then stained according to manufacturer’s protocol for phosphorylated
STAT-1. (N = 3)
Cell labeling and cytokine bead array (CBA)
Cells were harvested after 48 hours incubation at 37°Celsius in 7%CO2. Surface expression of
protein was determined using specific antibodies: CD209 (Becton Dickinson), CD40 (Becton
Dickinson), CD1a (Becton Dickinson), CD163 (R&D systems), Jagged1 (R&D systems), CD14
(Becton Dickinson) and IgG controls (Becton Dickinson). Phosphorylated STAT-1 levels were
determined using Anti-Human phospho-STAT1 (eBiosciences). Cytometric Bead Arrays
(CBA) were used to characterize TLR2/1R activated CD14+MF supernatants. CBAs were per-
formed on 50μL of supernatant that was harvested after 24 hours of incubation. Supernatants
were tested for the presence of MIP1-β, IL-6 and TNF-α. CBA Flex kits were obtained from
Becton Dickinson and performed according to manufacturer’s recommendations. Samples
were acquired using FacsCalibur and FacsVerse flow cytometers and FCS files were analyzed
using FlowJo software.
MΦ TLR activation cytokine response
PBMC/EC Co-cultures were harvested after 48 hours of incubation and CD14+MF were subse-
quently purified using a CD14 positive selection bead assay (Miltenyi Biotec) (purity> 95%).
CD14+MF from each condition (DMSO, IFN-γ and 105A10) were plated in equal number in
96 well flat bottom plates and stimulated with 10μg/ml TLR2/1 ligand (EMCMicrocollections).
After 24 hours of stimulation supernatants were harvested and characterized by CBA for pro-
duction of MIP1-β, TNF-α and IL-6.
Real time PCR
cDNA was generated using iScript cDNA synthesis reagent (Biorad) following manufacturers
guidelines. Primers (IDT) were used for determining mRNA expression of CYP27b, CAMP,
VDR, and JAG1. SYBR Green PCRMaster Mix (BioRad) was used for Real Time PCR reactions
and data was normalized to h36B4 gene expression (IDT). Expression values were calculated as
previously described [7].
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Vitamin D pathway regulation
CD14+MF from co-cultures were harvested and purified as previously mentioned. After puri-
fication, MF were plated in 10% FCS with 25-D3 (10
−8 M) (Biomol) and incubated for 24 hrs.
Cells were then harvested and analyzed for CAMP, VDR and Cyp27b1 gene expression by
qPCR.
Antimicrobial assays
Viable bacteria stocks ofM. leprae were obtained from Dr. James L. Krahenbuhl of the National
Hansen's Disease Programs, Health Resources Service Administration, Baton Rouge, LA. For
antimicrobial assays, Endothelial/PBMC co-cultures were set up as previously mentioned.
After 48 hours of incubation CD14+ MF (>90% CD209+) were isolated from co-cultures for
infection withM. leprae. Co-culture conditioned (Media, IFN-γ and sJAG1) CD14+ MF were
cultured in RPMI with 10% FCS (Omega Scientific) in the presence of liveM. leprae (MOI
10:1). Infected cells were subsequently stimulated with IFN-γ (10ng/ml) in the presence of
25-D3 (10
−8 M) after 24 hours of infection. To measure antimicrobial activity inM. leprae-
infected MF (5 days post infection) we followed the protocol as previously described [40, 42].
In short, qPCR was performed to determine levels of bacterial 16S rRNA and genomic element
DNA (RLEP). Expression levels of h36B4 were also evaluated to determine infectivity between
all the conditions. TheM. leprae 16S rRNA and RLEP primers used were as previously
described [25, 26].
Phagocytosis andM. leprae uptake assay
DiI (1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlorate)-labeled CuSO4-oxi-
dized low density lipoprotein (Dil-Ox-LDL) from Intracel was added to co-cultures after 44
hours and further cultured for 4 hours in the presence of Dil-OxLDL to allow for uptake
(50μg/ml). After incubation, Dil-OxLDL levels were determined within the CD209+ population
of our stained cultures. To determineM. leprae uptake (S12 Fig), CD14+ MF were harvested
from co-cultures as previously mentioned and infected with labeledM. leprae. After 24 hours
of infection MF were harvested and stained for CD209, CD14 and CD163 expression.
IHC and confocal microscopy
Immunoperoxidase and immunofluorescence labeling were carried out on frozen patient tissue
sections. For immunoperoxidase staining, samples were initially blocked with normal horse or
goat serum prior to labeling with monoclonal antibodies (JAG1 (Abcam), vWF (AbD Serotec),
CD163 (AbD Serotec) and appropriate isotype controls). Sections were then labeled with bioti-
nylated horse anti-mouse IgG or biotinylated goat anti-rabbit IgG. After labeling, sections were
counterstained with hematoxylin and visualized using the ABC Elite system (Vector Laborato-
ries). In order to determine protein co-localization in tissue sections, two-color immunofluores-
cence and confocal microscopy were performed. For Immunofluorescence, sections were
labeled with rabbit anti-human JAG1, anti-CD163 (IgG1), anti-CD209 (IgG2b), anti-vWF
(IgG1) and appropriate isotype controls. Subsequently samples were labeled with isotype-spe-
cific, fluorochrome (A488 or A568)-labeled goat anti-mouse/rabbit immunoglobulin antibodies
(Molecular Probes). Nuclei were stained with DAPI (4',6'-diamidino-2-phenylindole). Double
immunofluorescence of skin sections was examined using a Leica-TCS-SP MP inverted single
confocal laser scanning and a two-photon laser microscope (Leica, Heidelberg, Germany) at the
Advanced Microscopy/Spectroscopy Laboratory Macro-Scale Imaging Laboratory, California
NanoSystems Institute, University of California at Los Angeles [26]. Blinded review of IHC
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samples was carried out and positive staining was scored on the scale of 0 (absent) to 4 (highest
staining) relative to isotype controls. Fishers exact test was used to determine significance.
Transfections
siRNA transfections were carried out on 2x104 HUVEC in 96 well plates and 7x103 HUVEC in
384 well plates. siRNA for candidate genes, siControl and siGlow were obtained from Dharma-
con as was the transfection reagent Dharmafect 4. siRNA transfections were performed accord-
ing to manufacturer’s recommendations using 100nM concentration of siRNA. Decrease in
message in transfected cells was confirmed by qPCR and protein expression. Ectopic expres-
sion cassettes for JAG1, GFP and M11-empty vector were obtained from Genecopoeia. Plasmid
transfections were carried out on HUVEC that were grown to 80–90% confluence. HUVEC
were harvested and transfected with 1μg DNA using the AMAXA transfection device and
HUVEC Nucleofect kit (Lonza). To determine transfection efficiency, control cells were char-
acterized for GFP production. In addition, surface expression of transfected JAG1 was con-
firmed by flow cytometry.
Microarrays
For microarrays performed on compound and cytokine treated HUVEC, ECs were seeded in 6
well plates at 1X106 cells/well. Single wells were stimulated for five hours with DMSO, IFN-γ,
IFN-α and compounds 104B11, 104C2, 105A9 and 105A10 at concentrations noted earlier.
After incubation, mRNA was harvested using Trizol (Invitrogen), followed by RNeasy Mine-
lute Cleanup Kit (Qiagen). mRNA samples for all arrays were processed using the Affymetrix
Human U133 plus 2 platform and analyzed as previously described [22].
Statistical analysis
Statistical significance (<.05) of experimental values was calculated using a paired two-tailed
Student’s t-test. Hypergeometric p values were calculated using the online resource (http://
systems.crump.ucla.edu/hypergeometric) (Tom Graeber laboratory, UCLA).
Ethics statement
Patient samples were obtained with approval from the IRB of the University of California Los
Angeles, the Institutional Ethics Committee of Oswald Cruz Foundation and the University of
Southern California School of Medicine. All subjects were legal adults and provided written
informed consent before participating in the study [26].
Supporting Information
S1 Fig. Contact with vascular endothelium uniquely drives CD209+MF differentiation. (A)
Contact with vascular endothelium and not smooth muscle cells facilitates monocyte differen-
tiation into CD209+MF. Histograms are representative of three independent experiments per-
formed in triplicate.
(TIF)
S2 Fig. CD1a expression on EC-driven CD209+MF subsets. Log scale dot plots are represen-
tative of more than three independent donors performed in triplicate.
(TIF)
S3 Fig. Characterization of EC-driven antimicrobial CD209+MF differentiation. (A) Trans-
well experiments. EC were cultured in the upper chamber and treated with IFN-γ, with primary
Jagged1 Instructs Macrophage Differentiation in Leprosy
PLOS Pathogens | DOI:10.1371/journal.ppat.1005808 August 17, 2016 14 / 18
monocytes in the lower chamber. Histograms are representative of three independent donors
performed in triplicate (B) IFN-γ treatment of HUVEC triggers purified CD14+ monocyte dif-
ferentiation into antimicrobial CD209+MF. Data represent the mean +/- SEM from at least
three independent donors ( p value< 0.05). (C) Treatment of PBMC with IFN-γ did not pro-
mote CD209+MF differentiation. Histograms are representative of more than three indepen-
dent donors performed in triplicate.
(TIF)
S4 Fig. Direct stimulation of monocytes with active compounds does not trigger antimicro-
bial CD209+MF differentiation. Stimulation of PBMC with active compounds (105 A9-A10,
104 B11-C2) did not result in the differentiation of CD209+MF. Histograms are representative
of more than three independent donors performed in triplicate.
(TIF)
S5 Fig. Differential effects of naphthyridine analogs in EC-driven antimicrobial
CD209+MF differentiation. EC were treated with either media (m), IFN-γ (γ), 105A10, or
naphthyridine analogs followed by co-culture with peripheral blood mononuclear cells. Data
represent the mean +/- SEM from at least three independent donors.
(TIF)
S6 Fig. siRNA screen of candidate genes involved in EC facilitated antimicrobial CD209
+MF differentiation. (A) Data represent the mean +/- SEM from five independent donors.
(B) Validation of JAG1 mRNA knockdown by qPCR. Data represent the mean +/- SEM from
at least three independent experiments.
(TIF)
S7 Fig. JAG1 expression on activated EC. EC were cultured with or without IFN-γ and then
assessed for JAG1 expression by flow cytometry. Data represent the mean +/- SEM from two
independent experiments; filled histogram represents staining observed with isotype control.
(TIF)
S8 Fig. JAG1 expression in T-Lep and L-Lep biopsies. Immunohistochemistry (T-lep, n = 3
and L-lep, n = 3) staining of JAG1, vWF and IgG isotype controls. Positive staining of target
proteins (JAG1 or vWF) is represented by red staining.
(TIF)
S9 Fig. Stimulation of EC-monocyte co-cultures with multiple forms of Jag1. (A) Ectopic
expression of JAG1 in transfected EC facilitates antimicrobial CD209+MF differentiation.
Data represent the mean +/- SEM from at least three independent donors ( p value< 0.05)
(B) Surface expression of JAG1 on M11-JAG1 transfected HUVEC. Histogram is representa-
tive of at least three independent experiments. (C) Addition of either JAG1 active peptide or
soluble JAG1-fc protein to EC/PBMC co-culture facilitates CD209+CD163negMF differentia-
tion. Data represent the mean +/- SEM from at least three independent donors. ( p
value< 0.05). (D) Dose titration of soluble JAG1-fc active protein to EC/PBMC co-culture.
Data represent the mean CD163MFI on CD209+ MF (+/- SEM from at least two independent
donors. ( p value< 0.05)).
(TIF)
S10 Fig. Stimulation of monocytes with sJAG1. Direct stimulation of PBMC does not induce
the differentiation of CD209+MF. Histograms are representative of more than three indepen-
dent donors performed in triplicate.
(TIF)
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S11 Fig. Induction of NOTCH1 target genes in M1 MF. EC-monocyte co-cultures were
treated with (black bars) or without (white bars) sJAG1 and after 2 days. NOTCH1 target gene
expression was quantified by qPCR (p values: 0.02, 0.01, and 0.006 for HES1, SOCS3 and RBPJ,
respectively).
(TIF)
S12 Fig. LabeledM leprae uptake experiments. To determine uptake ofM leprae during kill-
ing assays we used labeledM leprea (PE) and determined percent of CD209+ macrophages
that had taken upM leprea by flow cytometry. Data represents three independent donors per-
formed in triplicate. ( p value< 0.05).
(TIF)
S1 Table. Candidate genes used in siRNA screen. Top fifty candidate genes used in siRNA
screen. Fold change of gene expression in treated over media control HUVEC samples from
microarray assays. In addition, the fold change of gene expression in T lep vs L lep tissue biopsy
microarrays(BT/LL) and P-values (represent significance of differences in gene expression in T
lep and L lep tissue biopsy microarrays) are displayed in the right two columns.
(TIF)
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